Emergency contraception
- Autores: Bebneva T.N.1
-
Afiliações:
- Peoples' Friendship University of Russia
- Edição: Volume 27, Nº 6 (2020)
- Páginas: 88-91
- Seção: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/312684
- DOI: https://doi.org/10.18565/pharmateca.2020.6.88-91
- ID: 312684
Citar
Texto integral
Acesso aberto
Acesso está concedido
Acesso é pago ou somente para assinantes
Acesso está concedido
Acesso é pago ou somente para assinantes
Resumo
The review presents modern data on the currently used methods of emergency contraception (EC) (non-pharmacological and hormonal), the features of their use and effectiveness. Levonorgestrel-containing tablets (Escapel) is the most popular EC product, it provides a contraceptive effect with a probability of pregnancy of only 1.1%. The safety of a single dose of 1.5 mg of levonorgestrel is confirmed by the results of numerous studies. In the Emergency Contraception Consortium, this regimen is recommended as a first-choice method.
Texto integral
Sobre autores
Tamara Bebneva
Peoples' Friendship University of Russia
Email: bebn@mail.ru
Cand. Sci. (Med.), Associate Professor at the Department of Obstetrics, Gynecology and Reproductive Medicine, Faculty of Continuous Education of Medical Workers, Medical Institute
Bibliografia
- Петров Ю.А., Байкулова Т.Ю. Современные пред -ставления о проблеме искусственного прерывания беременности. Международный журнал прикладныхи фундаментальгных исследований. 2016;8:727-31. [Petrov Yu.A., Baykulova T.Yu. Modern ideas about the problem of artificial termination of pregnancy Mezhdunarodnyi zhurnal prikladnykh i fundamental'nykh issledovaniy. 2016;8:727-31. (in Russ.)].
- Wu S., Godfrey E.M., Wojdyla D., et al. Copper T380A intrauterine device for emergency contraception: a prospective, multicentre, cohort clinical trial. BJOG. 2010;117(10):1205-10.
- Turok D.K., Godfrey E.M., Wojdyla D., et al. Copper T-380 intrauterine device for emergency contraception: highly effective at any time in the menstrual cycle. Hum. Reprod. 2013;28(10):2672-76. doi: 10.1093/humrep/ det330.
- Goldstuck N.D., Cheung T.S. The efficacy of intrauterine devices for emergency contraception and beyond: a systematic review update. int J Womens Health. 2019;11:471-79. Doi:10.2147/ JWH.S213815.
- Turok D.K., Sanders J.N., Thompson i.S., et al. Preference for and efficacy of oral levonorgestrel for emergency contraception with concomitant placement of a levonorgestrel iUD: a prospective cohort study. Contraception. 2016;93(6):526 32. Doi:W.W16/j.contraception.2016.01.009
- Yuzpe A.A, Thurlow H.J., Ramzy i., Leyshon J.i. Post coital contraception - A pilot study. J Reprod Med. 1974;13(2):53-8.
- Curtis K.M., Jatlaoui T.C., Tepper N.K., et al. U.S. selected practice recommendations for contraceptive use, 2016. MMWR Recomm Rep. 2016;65(4):1-66. doi: 10.15585/mmwr. rr6504a1.
- American College of Obstetricians and Gynecologists. Practice Bulletin No. 152: emergency contraception. Obstet Gynecol. 2015;126(3):e1-11. doi: 10.1097/A0G.0000000000001047.
- Martinez G., Copen C.E., Abma J.C. Teenagers in the United States: sexual activity, contraceptive use, and childbearing, 2006-2010 national survey of family growth. Vital Health Stat. 2011; (31):1-35.
- Piaggio G., Heng Z., von Hertzen H., et al. Combined estimates of effectiveness of mifepristone 10 mg in emergency contraception. Contraception. 2003;68(6):439-46.
- Pharma H.R.A. FDA advisory committee unanimously recommends approval of HRA pharma's ulipristal acetate for emergency contraception. 2010. Available at: https:// ec.princeton.edu. Accessed January 7, 2019.
- Medical eligibility criteria for contraceptive use. 5th ed. Switzerland: WHO, 2015. 267 р
- Emergency contraceptive pills. Medical and Service Delivery Guidance. international Consortium for Emergency Contraception, international Federation of Gynecologists and Obstetricians. 4th ed. 2018. 24 р. Available at: https://www.cecinfo.org
- Casteel C., Martin S.L., Smith J.B., et al. National study of physical and sexual assault among women with disabilities. inj Prev. 2008;14(2):87-90.
- Glasier A., Cameron S.T., Fine P.M., Logan S.J., Casale W., Van Horn J., et al. Ulipristal acetate versus levonorgestrel for emergency contraception: a randomized noninferiority trial and meta-analysis. Lancet. 2010;375:555-62. doi: 10.1016/S0140-6736(10)60101-8.
- WHO. Model list of essential medicines. 19th ed. Geneva: WHO, 2015. Available at: http:// mednet3.who.int/EMLib.
- Cleland K., Raymond E.G., Westley E., Trussell J. Emergency contraception review: evidence-based recommendations for clinicians. Clin Obstet Gynecol. 2014;57(4):741-50. Doi:10.1097/ GRF.0000000000000056.
- Дикке ГБ. Пять шагов к успешной контрацепции: Руководство для врачей. М., 2017. 430 с. [Dikke G.B. Five Steps to Successful Contraception: A Guide for Physicians. M., 2017. 430 p. (In Ruuss.)].
- Бебнева Т.Н. Применение Эскапела - средства для экстренной контрацепции у женщин в различные возрастные периоды. Основы консультирования. РМЖ. 2007;2:134. [Bebneva T.N. Application of Escapel-means for emergency contraception in women in different age periods. Basics of consulting. Russkiy meditsinskiy zhurnal. 2007;2:134. (in Ruuss.)].